Brief: Rakovina Therapeutics Presents Preclinical Data On Its Novel KT-3000 Series At 2022 AACR Special Conference On Sarcomas
11/05/2022 14:12
May 11 (Reuters) - Rakovina Therapeutics Inc RKV.V :
* RAKOVINA THERAPEUTICS PRESENTS PRECLINICAL DATA ON ITS
NOVEL
KT-3000 SERIES AT 2022 AACR SPECIAL CONFERENCE ON SARCOMAS
Source text for Eikon: ID:nGNX621Bq2
Further company coverage: RKV.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rakovina Therapeutics
See all newsBrief: Rakovina Therapeutics Announces Three-Month Q2 Ended June 30, 2025 Financial Results And Provides Corporate Update
Brief: Rakovina Therapeutics Announces The Closing Of Oversubscribed Private Placement Of $4.9 Million
Brief: Rakovina Therapeutics Appoints David Kideckel As Chief Financial Officer
Brief: Rakovina Therapeutics Announces 2024 Financial Results
Brief: Rakovina Therapeutics Announces Successful Synthesis Of Novel Small-Molecule Drug Candidates Designed Under AI Platform Collaboration